Posted on November 29, 2016

PRESS RELEASE OF THE ASSOCIATION OF THE RELATIVES OF THE VICTIMS  (AFEVA) 

The Association of the Relatives of Asbestos Victims (AFEVA) of Casale Monferrato and Cavagnolo and the CGIL, CISL and UIL Trade unions wish to release the following statement with reference to the today’s ruling by the Turin preliminary hearing magistrate (GUP) on the so called Eternit-bis trial: 

We waited two years for this result and words cannot describe all the feeling the great effort with nothing to show for has left us with. 

Continue reading →

Posted on September 29, 2016

Lou Williams, GBAN Australian National Director

My next venture will be to Brisbane to speak at the Asbestos Disease Support Society (ADSS) Symposium on the 19 October. I am particularly looking forward to catching up with other Meso Warriors after the event for a high tea so we can all have a big hug session. These events are very special to my heart. I will be joining three expert speakers at the Symposium who will aim to educate us on asbestos related disease from their perspective. Professor Niko van Zandwijk from ADRI will touch on the many advancements and developments in the treatment for Mesothelioma. Dr Katherine Semple will be clarifying the distinction between the various asbestos related diseases and Dr Edwards will talking about how chest X-rays and CT scans can be used to diagnose asbestos disease. I will be talking about my journey and my fight to have Keytruda put on the pharmaceutical benefits scheme her in Australia. I understand that the speakers will be filmed and their sessions available on the ADSS website www.adss.org.au shortly after the event. Should people wish to attend they can contact ADSS on 1800 776 412.

Lou Williams, GBAN Australian Director

Posted on September 10, 2016

Please read and share this update on my journey with Keytruda and my efforts to have it made available to mesothelioma patients through Australia’s Pharmacetical Benefits Scheme (PBS). Currently Keytruda is on PBS for Melanoma cancer only (as of Sept 2015).  Melanoma patients now pay $6 for infusions of Keytruda while patients who are having Keytruda as a life saving drug pay $5,000 to $10,000 per infusion! I know firsthand the benefits of this drug: I have been battling mesothelioma for 13 years, but thanks to Keytruda I am able to continue doing asbestos advocacy work daily, in particular serving as a resource for newly diagnosed patients.

Please join thousands of others and sign my petition to help make this life-saving drug available to Australia’s Mesothelioma Warriors!

PETITION UPDATE: Lou Williams back on Keytruda after break of 6 months!

Lou Williams, GBAN Australian National Director

Continue reading →